These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36778825)

  • 21. Anxiolytic effects of the novel α
    Murasawa H; Kobayashi H; Saeki K; Kitano Y
    Psychopharmacology (Berl); 2020 Jan; 237(1):189-197. PubMed ID: 31515584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo-controlled phase III study in Asian patients.
    Baba M; Matsui N; Kuroha M; Wasaki Y; Ohwada S
    J Diabetes Investig; 2019 Sep; 10(5):1299-1306. PubMed ID: 30672128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somnolence and Dizziness During Mirogabalin Treatment in Patients With Neuropathic Pain Related to Lumbar Disease Who Switched From Pregabalin: A Retrospective Study.
    Akazawa T; Inoue G; Tanaka M; Umehara T; Nagai T; Oshita Y; Imura T; Miyagi M; Saito W; Sako K; Nomura S; Hiyama A; Katoh H; Sakai D; Sato M; Yoshida A; Iinuma M; Niki H; Takaso M; Watanabe M
    Global Spine J; 2023 Jun; 13(5):1319-1324. PubMed ID: 34325544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Effect of Mirogabalin on Peripheral Neuropathic Pain due to Lumbar Spine Disease.
    Kim K; Isu T; Kokubo R; Iwamoto N; Morimoto D; Kawauchi M; Morita A
    Asian Spine J; 2021 Jun; 15(3):349-356. PubMed ID: 32872751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia.
    Ushida T; Katayama Y; Hiasa Y; Nishihara M; Tajima F; Katoh S; Tanaka H; Maeda T; Furusawa K; Richardson M; Kakehi Y; Kikumori K; Kuroha M
    Neurology; 2023 Mar; 100(11):e1193-e1206. PubMed ID: 36517235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the dose titration and adherence of mirogabalin in patients with peripheral neuropathic pain depending on renal function: a nationwide electronic medical record database study.
    Kato K; Kodama S; Shiosakai K; Kimura T
    Expert Opin Pharmacother; 2023 Feb; 24(2):267-282. PubMed ID: 36503333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mirogabalin, a novel ligand for α
    Murasawa H; Pawlak A; Kobayashi H; Saeki K; Yasuda SI; Kitano Y
    Biomed Pharmacother; 2021 Jul; 139():111647. PubMed ID: 33940507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mirogabalin: First Global Approval.
    Deeks ED
    Drugs; 2019 Mar; 79(4):463-468. PubMed ID: 30778848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study.
    Merante D; Rosenstock J; Sharma U; Feins K; Hsu C; Vinik A;
    Pain Med; 2017 Nov; 18(11):2198-2207. PubMed ID: 28371941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological, pharmacodynamics, and clinical profile of mirogabalin besylate (Tarlige
    Kitano Y; Kai K; Yamamura N; Yoshiba S; Kuroha M
    Nihon Yakurigaku Zasshi; 2019; 154(6):352-361. PubMed ID: 31787689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness of Mirogabalin for the Treatment of Diabetic Peripheral Neuropathic Pain in Taiwan.
    Gray E; Ye X; Wang YF; Wang SJ
    Value Health Reg Issues; 2021 May; 24():148-156. PubMed ID: 33582418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of mirogabalin treatment in patients with diabetic peripheral neuropathic pain: A systematic review and meta-analysis of randomised controlled trials.
    Alyoubi RA; Alshareef AA; Aldughaither SM; Aljaroudi AM; Alabdulwahed A; Alduraibi FM; Masoud AT; Abu-Zaid A
    Int J Clin Pract; 2021 May; 75(5):e13744. PubMed ID: 32991782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
    Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
    Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mirogabalin in Japanese Patients with Renal Impairment and Pain Associated with Diabetic Peripheral Neuropathy or Post-Herpetic Neuralgia: A Phase III, Open-Label, 14-Week Study.
    Baba M; Takatsuna H; Matsui N; Ohwada S
    J Pain Res; 2020; 13():1811-1821. PubMed ID: 32765056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donepezil, an Acetylcholinesterase Inhibitor, Can Attenuate Gabapentinoid-Induced Somnolence in Patients with Neuropathic Pain: A Retrospective Chart Review.
    Kogure T; Sumitani M; Ikegami K; Abe H; Hozumi J; Inoue R; Kawahara K; Yamada Y
    J Pain Palliat Care Pharmacother; 2017 Mar; 31(1):4-9. PubMed ID: 28287355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abuse potential of mirogabalin in recreational polydrug users.
    Mendell J; Levy-Cooperman N; Sellers E; Vince B; Kelsh D; Lee J; Warren V; Zahir H
    Ther Adv Drug Saf; 2019; 10():2042098619836032. PubMed ID: 31057786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of a new voltage-gated Ca
    Kato J; Inoue T; Yokoyama M; Kuroha M
    Expert Opin Pharmacother; 2021 Dec; 22(17):2311-2322. PubMed ID: 34431423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Mirogabalin on Hyperalgesia and Chronic Ocular Pain in Tear-Deficient Dry-Eye Rats.
    Kikuchi K; Tagawa Y; Murata M; Ishida S
    Invest Ophthalmol Vis Sci; 2023 May; 64(5):27. PubMed ID: 37233999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analgesic effects of mirogabalin, a novel ligand for α
    Saeki K; Yasuda SI; Kato M; Kano M; Domon Y; Arakawa N; Kitano Y
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):723-728. PubMed ID: 30770951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding Characteristics and Analgesic Effects of Mirogabalin, a Novel Ligand for the
    Domon Y; Arakawa N; Inoue T; Matsuda F; Takahashi M; Yamamura N; Kai K; Kitano Y
    J Pharmacol Exp Ther; 2018 Jun; 365(3):573-582. PubMed ID: 29563324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.